SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023987
Filing Date
2022-11-09
Accepted
2022-11-09 17:16:19
Documents
93
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q grna-20220930.htm   iXBRL 10-Q 3765409
2 EX-31.1 grna-ex31_1.htm EX-31.1 31537
3 EX-31.2 grna-ex31_2.htm EX-31.2 31339
4 EX-32.1 grna-ex32_1.htm EX-32.1 33889
  Complete submission text file 0000950170-22-023987.txt   14932988

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20220930_lab.xml EX-101.LAB 668631
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20220930_def.xml EX-101.DEF 548758
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20220930.xsd EX-101.SCH 98277
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grna-20220930_cal.xml EX-101.CAL 59710
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20220930_pre.xml EX-101.PRE 642620
87 EXTRACTED XBRL INSTANCE DOCUMENT grna-20220930_htm.xml XML 3046691
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39894 | Film No.: 221373699
SIC: 2836 Biological Products, (No Diagnostic Substances)